StockData
Colgate Palmolive Co logo

Colgate Palmolive Co (CL) KPIs and segments

CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$99.61−1.38 (-1.37%)

Close on Nov 17, 2026Market cap $79.18BP/E 39.1Yield 2.09%

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của Colgate Palmolive · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của Colgate Palmolive: 74 chỉ số vận hành, trong đó có Global Toothpaste Market Share, Year-to-Date, Global Manual Toothbrush Market Share, Year-to-Date và Worldwide Net Sales Mix by Product Category, lấy từ 192 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Oral, Personal and Home Care($M)6
4,1644,1664,1314,0343,9893,9543,7923,8043,9073,9443,9633,835
Latin America($M)
1,3261,3721,3131,2481,1781,2071,1431,1061,1561,2671,2531,193
Europe, Middle East & Africa($M)
1,1301,1211,1261,1151,0831,007
North America($M)
9058918881,3009229199041,0371,0041,0371,0351,047
Asia Pacific($M)
802782804555775746738725725682727698
Europe($M)
734801738690668744685673636
Africa/Eurasia($M)
309297295271268278273276261
Hill's Pet Nutrition($M)
1,2051,1951,1941,1421,1571,118
Pet Nutrition($M)
1,1961,1421,1571,1181,1411,1261,1141,1021,115
Oral, Personal and Home Care($M)
1,0421,0821,0309989929979719691,0161,0581,0441,009
Pet Nutrition($M)
286255264258274258235199231
Hill's Pet Nutrition($M)
267269280255264258
Latin America($M)
392418401359337367348339365417405367
Europe, Middle East & Africa($M)
262263266243241222
Asia Pacific($M)
211209222140213202204210199195207203
Europe($M)
182209184172156181169153151
North America($M)
177192141201199187197206206213214231
Africa/Eurasia($M)
656865575865646658
Hill's Pet Nutrition($M)
744747739685695681
Pet Nutrition($M)
734685695681676663655620
Latin America($M)
756789759696637680656637697763751
Europe, Middle East & Africa($M)
712716718698688640
North America($M)
524551498830541539546632623641645
Asia Pacific($M)
502491509335487462463461456422443
Europe($M)
467501463432419469427406
Africa/Eurasia($M)
183179178167155169168170
Hill's Pet Nutrition($M)
-23-15-22-21-22-21
Pet Nutrition($M)
-24-21-22-21-35-24-31-53
Oral, Personal and Home Care($M)
-85-90-77-122-103-68-68-127-81-62-47
Africa/Eurasia($M)
-4-4-2-2-6-3-1-1
Europe, Middle East & Africa($M)
-12-16-10-22-15-11
North America($M)
-13-18-14-19-17-13-16-22-9-13-8
Asia Pacific($M)
-22-18-14-29-18-19-13-23-22-10-9
Europe($M)
-25-18-12-8-30-13-13-8
Latin America($M)
-38-38-39-45-46-21-28-46-34-25-21
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)2
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)5
Global Toothpaste Market Share, Year-to-Date (%)(%)1
41.4%41.3%41.1%41.3%41.2%41.1%40.9%41.4%41.6%41.5%41.3%41.1%
Global Toothpaste Market Share YoY Change (share points)(%)
0.3%0.2%0.0%-0.5%-0.6%-0.5%0.5%0.9%1.0%
Global Manual Toothbrush Market Share, Year-to-Date (%)(%)1
33.1%32.7%32.6%32.4%32.4%32.4%31.9%32.2%32.3%32.2%31.7%31.5%
Global Manual Toothbrush Market Share YoY Change (share points)(%)
0.8%0.6%0.8%0.3%0.4%0.3%0.9%1.0%1.4%
Worldwide Net Sales Mix by Product Category (%)4
Oral Care (% of Worldwide Net Sales)(%)
44.0%44.0%44.0%44.0%43.0%44.0%44.0%42.0%43.0%
Personal Care (% of Worldwide Net Sales)(%)
17.0%18.0%17.0%18.0%18.0%17.0%18.0%19.0%18.0%
Home Care (% of Worldwide Net Sales)(%)
16.0%16.0%17.0%16.0%16.0%16.0%16.0%17.0%17.0%
Pet Nutrition (% of Worldwide Net Sales)(%)
23.0%22.0%22.0%22.0%23.0%23.0%22.0%22.0%22.0%
Worldwide Net Sales Mix by Operating Division (%)7
North America Share of Worldwide Net Sales (%)(%)
17.0%17.0%17.0%19.0%19.0%20.0%20.0%21.0%20.0%20.0%20.0%20.0%
Latin America Share of Worldwide Net Sales (%)(%)
25.0%26.0%25.0%24.0%23.0%24.0%23.0%22.4%23.0%25.0%25.0%24.0%
Europe, Middle East & Africa (EMEA) Share of Worldwide Net Sales (%)(%)
21.0%21.0%21.0%
Asia Pacific Share of Worldwide Net Sales (%)(%)
15.0%14.0%15.0%14.0%14.0%13.0%14.0%14.6%14.0%14.0%14.0%14.0%
Hill's Pet Nutrition Share of Worldwide Net Sales (%)(%)
22.0%22.0%22.0%23.0%22.0%23.0%23.0%23.1%22.0%22.0%22.0%23.0%
Europe (Legacy Structure through Q4 2025) Share of Worldwide Net Sales (%)(%)
14.0%16.0%14.0%14.0%13.5%15.0%14.0%14.0%14.0%
Africa/Eurasia (Legacy Structure through Q4 2025) Share of Worldwide Net Sales (%)(%)
6.0%6.0%6.0%6.0%5.4%6.0%5.0%5.0%5.0%
Organic Sales Growth YoY (%)(%)12
3.6%2.4%2.9%2.2%0.4%1.8%1.4%4.3%6.8%9.0%9.8%7.0%
Total Oral, Personal and Home Care(%)
3.1%2.4%3.1%2.5%0.9%1.7%1.0%4.7%6.8%9.8%11.4%7.5%
North America(%)
-1.6%-3.0%-2.2%-1.8%-0.5%-0.9%-3.0%-0.7%-1.9%2.5%4.0%3.5%
Latin America(%)
6.0%5.3%5.4%6.5%1.7%3.4%4.0%9.2%14.2%18.8%25.9%16.5%
Europe, Middle East & Africa (EMEA)(%)
2.7%2.0%3.5%
Asia Pacific(%)
4.6%5.2%5.6%0.1%-1.0%0.0%-3.1%3.8%6.1%5.1%1.5%1.0%
Hill's Pet Nutrition(%)
5.7%2.1%2.1%1.5%-1.3%2.0%2.9%2.9%6.5%6.1%4.2%4.5%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
5.4%4.8%6.2%4.5%1.0%2.8%1.7%7.5%11.1%14.6%15.7%10.5%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
2.3%0.5%0.2%0.5%-0.1%0.9%1.1%1.7%3.2%4.5%4.9%4.0%
Europe (Legacy Structure through Q4 2025)(%)
1.8%1.2%2.0%5.4%4.5%6.3%6.5%7.2%3.5%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
10.3%6.2%7.7%1.8%9.4%10.8%16.4%16.2%17.0%
Private-Label Pet Food Exit Impact on Consolidated Organic Sales Growth (%)(%)
-0.2%-0.4%-0.6%-0.9%-0.8%-0.6%-0.4%-0.5%
Private-Label Pet Food Exit Impact on Hill's Pet Nutrition Organic Sales Growth (bps)(bps)
-70-200-260-370-310-210
Organic Volume Change YoY (%)(%)10
1.7%0.8%0.6%-0.5%-1.9%-0.2%-0.1%2.5%3.7%4.7%1.3%0.0%
Total Oral, Personal and Home Care(%)
1.6%1.5%1.3%-0.1%-1.3%0.0%0.0%2.9%3.7%5.4%2.8%1.0%
North America(%)
-3.7%-3.9%-3.2%-2.3%-0.5%-0.4%-2.3%1.9%1.2%5.9%2.9%0.5%
Latin America(%)
3.9%2.6%2.0%2.3%-1.9%0.4%2.7%0.9%3.3%5.5%6.2%8.0%
Europe, Middle East & Africa (EMEA)(%)
3.5%3.2%2.2%
Asia Pacific(%)
1.9%4.1%4.6%-2.2%-3.5%-1.6%-3.4%5.8%6.5%3.4%-2.9%-4.5%
Hill's Pet Nutrition(%)
1.8%-1.8%-1.7%-1.5%-4.2%-0.9%-0.3%0.8%3.6%2.5%-3.9%-4.0%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
3.7%2.8%3.5%0.3%-2.6%0.2%0.2%3.7%4.6%5.6%2.2%2.5%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
0.1%-0.9%-1.7%-1.0%-1.4%-0.5%-0.4%1.5%3.0%4.0%0.6%-2.0%
Europe (Legacy Structure through Q4 2025)(%)
0.8%0.8%-0.2%3.0%1.7%4.1%5.2%3.1%-4.0%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
1.1%-1.1%4.3%-2.3%11.5%6.9%8.4%3.9%7.5%
As-Reported Volume Change YoY (Including Acquisitions & Divestments, %)(%)10
1.7%0.9%1.1%0.0%-1.5%0.0%-0.1%2.5%3.7%4.7%1.3%0.0%
Total Oral, Personal and Home Care(%)
1.6%1.5%1.3%-0.1%-1.3%0.0%0.0%2.9%3.7%5.4%2.8%1.0%
North America(%)
-3.7%-3.9%-3.2%-2.3%-0.5%-0.4%-2.3%1.9%1.2%5.9%2.9%0.5%
Latin America(%)
3.9%2.6%2.0%2.3%-1.9%0.4%2.7%0.9%3.3%5.5%6.2%8.0%
Europe, Middle East & Africa (EMEA)(%)
3.5%3.2%2.2%
Asia Pacific(%)
1.9%4.1%4.6%-2.2%-3.5%-1.6%-3.4%5.8%6.5%3.4%-2.9%-4.5%
Hill's Pet Nutrition(%)
1.8%-1.2%0.2%0.3%-2.6%0.1%-0.3%0.8%3.6%2.5%-3.9%-4.0%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
3.7%2.8%3.5%0.3%-2.6%0.2%0.2%3.7%4.6%5.6%2.2%2.5%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
0.1%-0.6%-0.9%-0.3%-0.7%-0.1%-0.4%1.5%3.0%4.0%0.6%-2.0%
Europe (Legacy Structure through Q4 2025)(%)
0.8%0.8%-0.2%3.0%1.7%4.1%5.2%3.1%-4.0%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
1.1%-1.1%4.3%-2.3%11.5%6.9%8.4%3.9%7.5%
Net Selling Price Change YoY (Pricing, Coupons & Trade Incentives, %)(%)10
2.0%1.6%2.2%2.7%2.3%2.0%1.5%1.8%3.1%4.2%8.5%7.0%
Total Oral, Personal and Home Care(%)
1.4%0.9%1.8%2.6%2.1%1.7%1.0%1.8%3.1%4.4%8.6%6.5%
North America(%)
2.2%0.9%1.0%0.5%0.1%-0.5%-0.7%-2.7%-3.2%-3.3%1.2%3.0%
Latin America(%)
2.1%2.8%3.4%4.2%3.6%3.0%1.2%8.3%10.9%13.3%19.7%8.5%
Europe, Middle East & Africa (EMEA)(%)
-0.9%-1.2%1.2%
Asia Pacific(%)
2.8%1.1%1.0%2.3%2.5%1.6%0.4%-2.0%-0.3%1.7%4.4%5.5%
Hill's Pet Nutrition(%)
3.9%3.9%3.8%3.0%2.9%2.9%3.2%2.0%2.8%3.7%8.2%8.5%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
1.7%1.9%2.7%4.2%3.6%2.6%1.4%3.8%6.5%9.0%13.5%8.0%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
2.2%1.3%1.9%1.5%1.3%1.4%1.5%0.3%0.2%0.4%4.3%6.0%
Europe (Legacy Structure through Q4 2025)(%)
1.0%0.4%2.2%2.4%2.7%2.2%1.3%4.1%7.5%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
9.1%7.3%3.4%4.1%-2.1%3.9%8.0%12.2%9.5%
Foreign Exchange Impact on Net Sales YoY (%)(%)10
1.0%2.4%5.1%3.1%1.2%-1.0%-4.4%-4.4%-4.4%-4.1%-3.6%0.0%
Total Oral, Personal and Home Care(%)
1.3%2.9%5.9%3.6%1.3%-1.5%-5.3%-5.5%-5.5%-5.0%-4.5%0.0%
North America(%)
-0.2%0.0%0.4%0.3%0.1%-0.1%-0.6%-0.3%-0.2%-0.1%0.0%0.0%
Latin America(%)
6.5%8.4%9.5%6.3%0.3%-8.2%-12.7%-16.4%-17.4%-11.2%-9.4%1.5%
Europe, Middle East & Africa (EMEA)(%)
-1.2%1.6%8.5%
Asia Pacific(%)
-1.1%-0.3%3.3%-0.4%-0.5%0.9%-1.9%0.0%0.2%-2.5%-3.0%-0.5%
Hill's Pet Nutrition(%)
-0.1%0.6%2.7%1.6%1.1%0.8%-1.4%-0.5%-0.1%-0.7%-0.3%0.5%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
2.7%4.4%6.7%4.3%0.6%-3.9%-7.9%-9.7%-10.1%-8.6%-8.1%-1.5%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
-0.3%0.9%3.9%2.2%1.7%1.4%-1.5%-0.2%0.4%-0.4%0.2%1.5%
Europe (Legacy Structure through Q4 2025)(%)
8.1%6.4%5.7%-2.9%0.4%1.6%-0.2%2.3%6.5%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
4.7%0.6%0.2%-3.4%-6.6%-6.0%-14.3%-20.7%-21.0%
As-Reported Net Sales Growth YoY (%)(%)10
4.6%4.9%8.4%5.8%2.0%1.0%-3.1%-0.1%2.4%4.9%6.2%7.0%
Total Oral, Personal and Home Care(%)
4.4%5.4%8.9%6.0%2.1%0.2%-4.3%-0.8%1.3%4.7%6.8%7.5%
North America(%)
-1.7%-3.0%-1.8%-1.5%-0.4%-1.0%-3.6%-1.0%-2.1%2.5%4.0%3.5%
Latin America(%)
12.5%13.7%14.8%12.8%2.0%-4.8%-8.7%-7.2%-3.2%7.6%16.5%18.0%
Europe, Middle East & Africa (EMEA)(%)
1.4%3.5%11.9%
Asia Pacific(%)
3.5%4.9%8.9%-0.3%-1.5%0.8%-5.0%3.7%6.3%2.6%-1.5%0.5%
Hill's Pet Nutrition(%)
5.6%3.4%6.7%4.9%1.4%3.8%1.5%2.3%6.3%5.5%3.9%5.0%
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%)
8.0%9.2%12.9%8.7%1.6%-1.1%-6.2%-2.2%1.0%5.9%7.5%9.0%
Developed Markets (North America, Western Europe, Japan & Australia)(%)
2.0%1.6%4.9%3.5%2.3%2.8%-0.4%1.6%3.6%4.0%5.1%5.5%
Europe (Legacy Structure through Q4 2025)(%)
9.8%7.6%7.8%2.5%4.9%8.0%6.2%9.5%10.0%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
15.0%6.8%8.0%-1.5%2.8%4.8%2.2%-4.5%-4.0%
Segment Operating Profit Growth YoY (%)7
North America(%)
-11.0%3.0%-28.0%-1.0%-8.0%-9.0%-8.0%-11.0%-9.0%-2.0%15.0%19.0%
Latin America(%)
17.0%14.0%15.0%6.0%-8.0%-12.0%-14.0%-8.0%-2.0%15.0%29.0%26.0%
Europe, Middle East & Africa (EMEA)(%)
8.0%9.0%20.0%
Asia Pacific(%)
-1.0%3.0%9.0%-11.0%-6.0%-4.0%-4.0%4.0%3.0%16.0%2.0%12.0%
Hill's Pet Nutrition(%)
5.0%2.0%8.0%4.0%-1.0%13.0%30.0%19.0%28.0%23.0%9.0%-1.0%
Europe (Legacy Structure through Q4 2025)(%)
17.0%16.0%9.0%12.0%3.0%10.0%19.0%24.0%35.0%
Africa/Eurasia (Legacy Structure through Q4 2025)(%)
13.0%5.0%1.0%-14.0%-1.0%-1.0%4.0%-3.0%-15.0%
Net Sales by Reportable Operating Segment ($M)($M)
5,3695,3615,3245,2305,1315,1104,9114,9445,0335,0585,0654,950
Cost of Sales by Reportable Operating Segment (ASC 280 Significant Expense, $M)7
North America Cost of Sales ($M)($M)
381340390391381380358310381396390
Latin America Cost of Sales ($M)($M)
570583554552541527487469459504502
Europe, Middle East & Africa (EMEA) Cost of Sales ($M)($M)
418405408393417395367
Asia Pacific Cost of Sales ($M)($M)
300291295290288284275330269260284
Hill's Pet Nutrition Cost of Sales ($M)($M)
461448455462457462437465463459482
Europe (Legacy Structure through Q4 2025) Cost of Sales ($M)($M)
218300275258268275258267
Africa/Eurasia (Legacy Structure through Q4 2025) Cost of Sales ($M)($M)
93118117104123109105106
Selling, General & Administrative Expenses by Segment (ASC 280 Significant Expense, $M)7
North America SG&A Expenses ($M)($M)
351362359333342349350139409426419
Latin America SG&A Expenses ($M)($M)
361377357332303318316305325353345
Europe, Middle East & Africa (EMEA) SG&A Expenses ($M)($M)
436438438425435428399
Asia Pacific SG&A Expenses ($M)($M)
296292289292280265264322264232242
Hill's Pet Nutrition SG&A Expenses ($M)($M)
475476456437427430422402406420413
Europe (Legacy Structure through Q4 2025) SG&A Expenses ($M)($M)
220285272254122280251245
Africa/Eurasia (Legacy Structure through Q4 2025) SG&A Expenses ($M)($M)
72106110106769910399
Other (Income) Expense, Net by Operating Segment (ASC 280, $M)7
North America Other (Income) Expense, Net ($M)($M)
-3-3-22-130-328313
Latin America Other (Income) Expense, Net ($M)($M)
2-614-2-6-7-77-61
Europe, Middle East & Africa (EMEA) Other (Income) Expense, Net ($M)($M)
14151422201918
Asia Pacific Other (Income) Expense, Net ($M)($M)
-6-10-2-3-6-6-5-2-8-6-7
Hill's Pet Nutrition Other (Income) Expense, Net ($M)($M)
22310201-1-119
Europe (Legacy Structure through Q4 2025) Other (Income) Expense, Net ($M)($M)
117779878
Africa/Eurasia (Legacy Structure through Q4 2025) Other (Income) Expense, Net ($M)($M)
4434-3515
Operating Profit by Reportable Operating Segment ($M)($M)2
1,0881,016964921,0591,0801,0761,0641,0651,0921,0471,072
North America Operating Profit ($M)($M)
177192141203199187197206206213214231
Corporate & Unallocated Operating Expense ($M)($M)
-221-335-346-1,194-189-181-153-179-208-201-196-169
Operating Profit Margin by Operating Segment (% of Segment Net Sales)(%)7
20.3%19.0%18.1%1.8%20.6%21.1%21.9%21.5%21.2%21.6%20.7%21.7%
North America Operating Margin (%)(%)
19.5%21.6%15.8%19.9%19.0%18.9%19.6%19.9%20.5%22.3%22.3%24.2%
Latin America Operating Margin (%)(%)
29.6%30.4%30.6%28.8%28.6%30.4%30.4%30.6%31.6%32.9%32.3%30.7%
Europe, Middle East & Africa (EMEA) Operating Margin (%)(%)
23.2%23.4%23.6%21.8%22.2%22.0%
Asia Pacific Operating Margin (%)(%)
26.4%26.7%27.6%26.0%26.2%27.2%28.7%29.1%27.4%28.7%28.5%29.0%
Hill's Pet Nutrition Operating Margin (%)(%)
22.2%22.5%23.4%23.9%22.4%22.9%23.1%24.1%22.9%21.1%18.0%20.7%
Europe (Legacy Structure through Q4 2025) Operating Margin (%)(%)
24.9%26.1%25.0%24.9%23.3%24.3%22.1%20.3%20.5%
Africa/Eurasia (Legacy Structure through Q4 2025) Operating Margin (%)(%)
21.1%23.0%22.0%21.0%21.5%23.4%23.4%23.9%22.3%
Operating Profit Margin YoY Change by Operating Segment (bps)(bps)7
-30-210-380-60-50120-20301401601,730
North America Operating Margin Change YoY (bps)(bps)
-210120-5900-150-170-100-220-170-90220310
Latin America Operating Margin Change YoY (bps)(bps)
100020-180-300-250-190-1040210300200
Europe, Middle East & Africa (EMEA) Operating Margin Change YoY (bps)(bps)
140120160
Asia Pacific Operating Margin Change YoY (bps)(bps)
-110-40-10-310-120-1502010-90320110300
Hill's Pet Nutrition Operating Margin Change YoY (bps)(bps)
-20-4030-20-5018051034039030080-130
Europe (Legacy Structure through Q4 2025) Operating Margin Change YoY (bps)(bps)
16018040220-4030230250380
Africa/Eurasia (Legacy Structure through Q4 2025) Operating Margin Change YoY (bps)(bps)
-40-40-140-290-80-1403030-300
Segment Gross Profit Margin YoY Change (bps, MD&A)4
North America(bps)
-70320-440-190-11090260
Latin America(bps)
29012040-620-400-260240350420
Asia Pacific(bps)
-4010050-60130270370160
Europe (Legacy Structure)(bps)
-4050240400410340
Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A)4
North America(bps)
350320210240170190190
Latin America(bps)
250260270320270250280260230
Asia Pacific(bps)
380270240330260240310210
Europe (Legacy Structure)(bps)
250240180280250270
Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A)3
Latin America(bps)
-80-260-370-780-570-460-380-480
Asia Pacific(bps)
-550-220-190-190-190
Europe (Legacy Structure)(bps)
-340-330-60120-200
Segment SG&A Expense Ratio YoY Change (bps, MD&A)2
Latin America(bps)
160120-40-250-150110170
Asia Pacific(bps)
701801011013080
Segment Advertising Investment Ratio YoY Change (bps, MD&A)1
Asia Pacific(bps)
1301202107031080
Segment Overhead Expense Ratio YoY Change (bps, MD&A)1
Asia Pacific(bps)
-6060-190904011070
Capital Expenditures by Reportable Operating Segment ($M)($M)9
134128138177155108124184134117126
Total Oral, Personal and Home Care Capital Expenditures ($M)($M)
8590771221036868127816247
North America Capital Expenditures ($M)($M)
13181417171316179138
Latin America Capital Expenditures ($M)($M)
3838394546212846342521
Europe, Middle East & Africa (EMEA) Capital Expenditures ($M)($M)
12161029221511
Asia Pacific Capital Expenditures ($M)($M)
221814311819132322109
Hill's Pet Nutrition Capital Expenditures ($M)($M)
2315222421222135243153
Corporate Capital Expenditures ($M)($M)
2623393131183522292426
Europe (Legacy Structure through FY2025) Capital Expenditures ($M)($M)
618128-213138
Africa/Eurasia (Legacy Structure through FY2025) Capital Expenditures ($M)($M)
242224311
Depreciation & Amortization by Reportable Operating Segment ($M)($M)9
159155156173158151148148150157150
Total Oral, Personal and Home Care Depreciation & Amortization ($M)($M)
100979610197959293939696
North America Depreciation & Amortization ($M)($M)
20201919201919-15303231
Latin America Depreciation & Amortization ($M)($M)
3130292827272423242627
Europe, Middle East & Africa (EMEA) Depreciation & Amortization ($M)($M)
27262733303029
Asia Pacific Depreciation & Amortization ($M)($M)
2221212120192021202020
Hill's Pet Nutrition Depreciation & Amortization ($M)($M)
3432354635313132333730
Corporate Depreciation & Amortization ($M)($M)
2526252626252523242424
Europe (Legacy Structure through FY2025) Depreciation & Amortization ($M)($M)
1816161516171616
Africa/Eurasia (Legacy Structure through FY2025) Depreciation & Amortization ($M)($M)
33222222
Consolidated GAAP Gross Profit Margin YoY Change (bps)4
Funding-the-Growth Productivity Savings Impact on Gross Margin (bps)(bps)
290280230290250210270280250
Net Selling Price Impact on Gross Margin (bps)(bps)
806080908060110160330
Product Mix & Other Impact on Gross Margin (bps)(bps)
20202030205040
Raw & Packaging Material Cost Inflation Impact on Gross Margin (bps)(bps)
-300-220-350-600-420-240-150-140-270
Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps)(bps)
901304013080160
Worldwide Advertising Investment ($M)($M)1
775777734682674678668648694706672593
Advertising Investment as % of Worldwide Net Sales (%)(%)
14.4%14.5%13.8%13.1%13.3%13.6%13.8%14.0%13.3%
Base Business (Non-GAAP) Gross Profit ($M)($M)
3,2383,2973,2263,1463,0493,0692,9872,9833,0833,0753,0392,950
Base Business (Non-GAAP) Gross Profit Margin (% of Net Sales)(%)1
60.3%61.5%60.6%60.2%59.4%60.1%60.8%60.3%61.3%60.8%60.0%59.6%
GAAP Gross Profit Margin (% of Net Sales)(%)
60.2%61.5%60.6%60.2%59.4%60.1%60.8%60.3%61.1%60.6%60.0%59.6%
Base Business (Non-GAAP) SG&A Expenses ($M)($M)3
2,1022,1222,0711,9801,9711,9631,8831,8941,9761,9371,9151,803
Base Business SG&A Expenses as % of Net Sales (%)(%)
39.1%39.6%38.9%37.9%38.4%38.4%38.3%38.3%38.3%37.8%
Base Business SG&A % of Net Sales YoY Change (bps)(bps)
7012060-4050170
GAAP SG&A Expenses as % of Net Sales (%)(%)
39.3%39.7%39.0%39.6%38.4%38.4%38.6%38.3%38.3%37.8%
Base Business (Non-GAAP) Operating Profit ($M)($M)1
1,1171,1451,1341,1081,0591,0891,0911,0711,0801,1181,0831,074
Base Business Other (Income) Expense, Net ($M)($M)
193021581917131827204173
Base Business (Non-GAAP) Operating Profit Margin (% of Net Sales)(%)2
20.8%21.4%21.3%21.2%20.6%21.3%22.2%21.7%21.5%22.1%21.4%21.7%
Base Business Operating Profit Margin YoY Change (bps)(bps)
2010-90-50-90-8080050150170140
GAAP Operating Profit Margin (% of Net Sales)(%)
20.3%19.0%18.1%1.8%20.6%21.1%21.9%21.5%21.2%21.6%20.7%21.7%
Base Business (Non-GAAP) Income Before Income Taxes ($M)($M)4
1,0491,0791,0681,0381,0161,0181,0011,0011,0361,003991
GAAP Non-Service Postretirement Costs ($M)($M)
242126-612123722023222222
Base Business Income Tax Provision ($M)($M)
244255248238236239216212247244229
Base Business Effective Income Tax Rate (%)(%)
23.3%23.6%23.2%22.9%23.2%23.4%21.6%21.2%23.8%24.3%23.1%
GAAP Effective Income Tax Rate (%)(%)
23.6%24.3%23.6%104.7%22.8%23.2%23.7%21.6%21.3%24.1%24.6%23.1%
Base Business (Non-GAAP) Net Income Attributable to Colgate-Palmolive ($M)($M)
777797784768750743745750753713720
Base Business (Non-GAAP) Diluted Earnings Per Share ($)($)
0.970.990.970.950.920.910.910.910.910.860.87
Total Common Shares Repurchased (shares)3
3,680,1673,223,3983,386,8505,089,0813,408,1212,560,7493,184,7664,795,2502,870,7764,827,0346,264,8732,884,952
Shares Repurchased Under Publicly Announced Board Programs (shares)
3,361,1093,195,4523,095,6565,073,6773,052,8592,550,0172,975,7674,775,9482,619,1614,820,7776,105,5362,839,064
Average Price Paid per Repurchased Common Share ($)($)
89.7087.4090.2878.5484.4790.6589.0494.5510393.2785.9375.89
Remaining Share Repurchase Program Authorization at Period-End ($M)($M)
3,2283,5303,8094,0874,4854,7444,9741,1831,6351,9042,3542,879
Free Cash Flow Before Dividends ($M)($M)
1,0378676091,2761,1067764761,0851,033873555939
Net Debt ($M, Earnings Release Definition)($M)2
6,1046,4046,5546,5936,9477,3466,9586,6936,9427,3417,3797,404
Marketable Securities ($M)($M)
858384107193197199160260225231179
Working Capital as % of Net Sales (%)(%)
-6.3%-5.9%-5.7%-7.0%-4.0%-2.9%-3.3%-5.2%-3.6%-2.5%-2.2%-1.4%
Commercial Paper Borrowings Outstanding at Period-End ($M)($M)1
1,0371,1491,2581471,2891,1151,1709361,2821,6071,599906
Average Daily Commercial Paper Borrowings During Period ($M)($M)
1,4051,3218931,7331,6941,4781,7541,6881,383
Restructuring & Productivity Program Accrual Balance at Period-End ($M)($M)2
172228164103436394451514111
Employee-Related Severance & Benefits Restructuring Accrual ($M)($M)
15321015562829313445483910
Incremental Asset-Related & Other Restructuring Accrual ($M)($M)
191894678106321
Colgate India — Product Sales, Net of GST (INR Lakhs)(M)1
169,157159,056158,277150,724142,064
Colgate India — Other Operating Revenue (INR Lakhs)(M)
1,4221,2741,2581,2261,342
Colgate India — Total Revenue from Operations (INR Lakhs)1
Colgate India — Total Income Including Interest & Other Income (INR Lakhs)(M)1
172,750162,610161,222153,453145,200
Colgate India — Other Non-Operating Income (INR Lakhs)(M)
2,1712,2801,6871,5031,794
Colgate India — Total Operating Expenses (INR Lakhs)(M)5
126,728116,057112,161109,225102,005
Colgate India — Cost of Raw & Packaging Materials Consumed (INR Lakhs)(M)
42,99243,27742,67939,36834,573
Colgate India — Purchases of Finished Stock-in-Trade (INR Lakhs)(M)
8,9448,9517,7138,4434,002
Colgate India — Employee Benefits Expense (INR Lakhs)(M)
13,59212,92612,08011,80611,820
Colgate India — Advertising & Brand Promotion Spend (INR Lakhs)(M)
31,48225,18619,90522,51018,841
Colgate India — Depreciation & Amortization Expense (INR Lakhs)(M)
3,4163,9213,5083,7193,754
Colgate India — Net Profit After Tax (INR Lakhs)(M)2
34,15734,30835,33232,75132,062
Colgate India — Profit Before Exceptional Items and Tax (INR Lakhs)(M)
46,02246,55349,06144,22843,195
Colgate India — Profit Before Tax (INR Lakhs)(M)
46,02246,21947,40344,22843,195
Consolidated Net Sales ($M)($M)3
5,3695,3615,3245,2305,1315,1104,9114,9455,0335,0585,0654,950
Cost of Sales ($M)($M)
2,1362,0652,0982,0842,0822,0411,9241,9631,9591,9922,0262,000
Gross Profit ($M)($M)
3,2333,2963,2263,1463,0493,0692,9872,9823,0743,0663,0392,950
Selling, General and Administrative Expenses ($M)($M)
2,1112,1302,0762,0701,9711,9631,8981,8961,9791,9391,9161,803
Consolidated Operating Profit ($M)($M)6
1,0881,016964921,0591,0801,0761,0631,0651,0921,0471,072
Interest Expense ($M)($M)
6262626467716666747873
Interest Income ($M)($M)
1717161921211516181815
Income Before Income Taxes ($M)($M)
1,0199508921089921,0079539939861,010967988
Provision for Income Taxes ($M)($M)
240231211113226234227214210243238228
Net Income Attributable to Noncontrolling Interests ($M)($M)
282635323130364039364642
Net Income Attributable to Colgate-Palmolive Company ($M)($M)
751693646-37735743690739737731683718
Diluted Earnings Per Common Share ($)($)4
000000000
Basic Earnings Per Common Share ($)($)
000000000
Dividends Declared Per Common Share ($)($)
000000000000
Weighted-Average Diluted Common Shares Outstanding (millions)(M)
800802805810813815823824826
Weighted-Average Basic Common Shares Outstanding (millions)(M)
797799802808810812818820823
Consolidated Total Assets ($M)($M)7
16,74216,79016,61016,33017,51317,47016,64716,04616,77416,48016,57116,393
Cash and Cash Equivalents ($M)($M)
1,5271,3701,3351,2881,2791,2151,1121,0961,2341,1101,079966
Receivables, Net ($M)($M)
1,9011,9621,8891,6751,8071,7731,7251,5211,7121,8251,8131,586
Inventories ($M)($M)
2,1822,1812,0862,0322,1092,1202,1251,9872,0411,9221,9141,934
Total Current Assets ($M)($M)
6,3576,3086,0825,7096,0395,9965,8145,3175,8065,6465,6405,279
Property, Plant and Equipment, Net ($M)($M)2
4,6134,6394,6224,6604,5604,5294,4164,4224,4214,3924,4974,582
Property, Plant and Equipment, Gross ($M)($M)
11,09711,02010,88710,85610,84710,66510,27610,12710,23810,16710,26110,286
Accumulated Depreciation ($M)($M)
-6,484-6,381-6,265-6,196-6,287-6,136-5,860-5,705-5,817-5,775-5,764-5,704
Goodwill ($M)($M)
3,0803,1003,1073,1223,7023,6963,3343,2723,3893,3203,3413,410
Other Intangible Assets, Net ($M)($M)
1,4721,4951,5211,5361,8891,9041,7821,7561,8341,8141,8371,887
Consolidated Total Liabilities and Shareholders' Equity ($M)($M)9
16,74216,79016,61016,33017,51317,47016,64716,04616,77416,48016,57116,393
Accounts Payable ($M)($M)
2,0962,1152,0962,0891,8661,7901,8001,8051,6251,5571,6461,698
Total Current Liabilities ($M)($M)
6,6396,1485,9346,8536,4966,7756,8615,7595,5655,3505,3144,741
Long-Term Debt ($M)($M)
7,1847,8237,9376,8717,3067,1446,5717,2897,9098,1468,1518,219
Total Liabilities ($M)($M)
16,10216,22416,12415,96516,27516,41815,91415,50215,93815,99815,95415,436
Retained Earnings ($M)($M)
27,41527,08526,81626,59527,05126,73526,41326,14525,81425,48625,16425,289
Common Stock in Treasury ($M)($M)
-29,201-28,931-28,656-28,450-28,057-27,821-27,602-27,358-26,913-26,736-26,343-26,017
Total Colgate-Palmolive Company Shareholders' Equity ($M)($M)
28823614554856702363212435123230609
Noncontrolling Interests ($M)($M)
352330341311382350370332401359387348
Total Equity ($M)($M)
6405664863651,2381,052733544836482617957
Net Cash Provided by Operations ($M)($M)8
1,1719957471,4531,2618846001,2691,1679906811,136
Capital Expenditures ($M)($M)
134128138177155108124184134117126197
Depreciation and Amortization ($M)($M)
159155156173158151148148150157150150
Stock-Based Compensation Expense ($M)($M)
633840287232232765241925
Net Cash Used in Investing Activities ($M)($M)
-137-122-122-103-154-401-159-80-150-111-193-143
Principal Payments on Share Repurchases ($M)($M)
330291306406288232284455295480509245
Net Cash Used in Financing Activities ($M)($M)
-858-851-563-1,361-1,028-409-458-1,279-904-845-361-992
Income Taxes Paid ($M)($M)
189283176201182391139171257355150211
Interest Paid ($M)($M)
783196359828109351063812337

8 chỉ số không có số liệu trong 12 quý gần nhất — .

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Primary operational metrics: global year-to-date market shares in toothpaste and manual toothbrushes, product category revenue mix (Oral Care, Personal Care, Home Care, Pet Nutrition), and the complete decomposition of top-line sales growth into organic volume, as-reported volume, net selling price, and foreign exchange across all operating divisions and Emerging vs. Developed markets.
  • Segment realignment (Q1 2026): effective January 1, 2026, Colgate-Palmolive combined its Europe and Africa/Eurasia operating segments (along with skin health) into Europe, Middle East & Africa (EMEA) and transferred its Russia and Belarus operations into Asia Pacific. Historical segment figures for FY2023–FY2025 are recast per Form 8-K filed March 17, 2026; legacy Europe and Africa/Eurasia series are preserved through Q4 2025.
  • ASC 280 significant segment expenses: segment-level Cost of Sales, Selling, General & Administrative (SG&A) expenses, and Other (income) expense, net are sourced from the Segment Information footnote and the October 2024 and March 2026 Form 8-K recasts.
  • All percentages, basis-point margin bridges, and growth rates are as reported by the company. The only computed cells are period detachments (Q4 = full year minus nine months; quarterly cash flow = year-to-date minus prior year-to-date), displayed in italics with their formula.
  • Colgate-Palmolive (India) Limited (NSE: COLPAL / BSE: 500830) is a 51%-owned, publicly listed Indian subsidiary; its self-reported financial, operational cost (including parent royalty and freight), and assured BRSR sustainability metrics are reported in INR Lakhs (Indian fiscal year ended March 31 mapped to the preceding calendar year).
  • No consolidated minus parent-only calculation is performed because Colgate-Palmolive reports under U.S. GAAP without standalone parent-only financial statements.

Không hiện vì thiếu các kỳ gần đây (25)

  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Gross Profit Margin YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Gross Profit Margin YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › North America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › North America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › North America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Latin America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › North America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Latin America
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
  • 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
  • 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP Gross Profit Margin YoY Change (bps)
  • 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps) › Advertising Investment Impact on SG&A Ratio YoY (bps)
  • 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps) › Overhead Expense Impact on SG&A Ratio YoY (bps)
  • 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Base Business (Non-GAAP) Income Before Income Taxes ($M) › Base Business Non-Service Postretirement Costs ($M)

Dữ liệu cập nhật 2026-11-04.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Colgate Palmolive

See a number that looks wrong?